Zobrazeno 1 - 9
of 9
pro vyhledávání: '"T. Panafidina"'
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/6d6f79106ca1416fa9bdfe64c8a1e9c9
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/681bc04d39074d5fb13649bf1a9c7652
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/97a8f431428b4849a54905c560645e91
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/ab50bb86c04d483fb4c907aba71dfeec
Publikováno v:
Thursday 06 October 2022 from 13:00 to 14:10.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f821bfed35ce8f152ca6e8e1df86cd86
https://doi.org/10.1136/lupus-2022-elm2022.94
https://doi.org/10.1136/lupus-2022-elm2022.94
Publikováno v:
Annals of the Rheumatic Diseases. 81:1312.2-1313
BackgroundThe role of galectin-3, a pro-inflammatory mediator involved in autoimmune disorders in patients with rheumatoid arthritis (RA), is discussed in the literature.ObjectivesTo clarify the relationship of clinical and laboratory manifestations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bf4c1b2661d0af25cfc1dca96903e1f
https://doi.org/10.1136/annrheumdis-2022-eular.4669
https://doi.org/10.1136/annrheumdis-2022-eular.4669
Publikováno v:
Annals of the Rheumatic Diseases. 81:1381-1381
BackgroundSystemic lupus erythematosus (SLE) has been strongly linked to accelerated atherosclerosis and increased cardiovascular morbidity and mortality.ObjectivesThe goal is to evaluate the traditional cardiovascular risk factors (TRF), intima-medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c82fdbb8deb6135ed3f4c7a67f665b94
https://doi.org/10.1136/annrheumdis-2022-eular.2695
https://doi.org/10.1136/annrheumdis-2022-eular.2695
Publikováno v:
Annals of the Rheumatic Diseases. 81:1846.2-1847
BackgroundThe prevalence of anti-DFS70 antibodies in healthy volunteers (HV) by various methods ranges from 0 to 22% [1]. This pattern, which is rare in patients with systemic autoimmune rheumatic diseases (SARDs), has been described as the second mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::455e9fc12bcc0a1ad63811bb5fae215a
https://doi.org/10.1136/annrheumdis-2022-eular.4545
https://doi.org/10.1136/annrheumdis-2022-eular.4545
Publikováno v:
European Heart Journal. 40
Background Nephritis in systemic lupus erythematosus (SLE) is a factor contributing to early development of atherosclerosis (AS). Objectives The aim of the study is to determine differences in cardiovascular risk factors and AS in SLE pts with and wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e176d7c4047192191d04acd724c5e703
https://doi.org/10.1093/eurheartj/ehz745.0850
https://doi.org/10.1093/eurheartj/ehz745.0850